课题基金 / 基金详情

项目摘要

项目成果

Rinad Sary Beidas的其他基金

相似基金

相关文献

中文摘要
翻译
这个P50应用程序代表了行为经济学交叉点的一个新的跨学科中心, 实施科学,以改善癌症护理服务。大学的行政核心 宾夕法尼亚州癌症控制实施科学中心(Penn ISC 3)将提供 业务和科学监督。它将由三位宾夕法尼亚大学ISC 3首席研究员Beidas博士领导, Bekelman和Schnoll与内部执行委员会和外部咨询委员会合作。 行政核心的具体目标如下:1)提供必要的管理和整合 宾夕法尼亚大学ISC 3活动(业务结构),其中包括行政支助、会议协调、 确保内部执行委员会和外部咨询委员会的有效利用;(2)服务于 作为宾夕法尼亚大学癌症实施科学(IS)研究的中心(IS外展),这将涉及 协调教育活动,利用宾夕法尼亚大学的重要伙伴关系,参与活动,以确保 沟通,与通过这一机制资助的其他中心合作,并协调年度务虚会; (3)协调中心研究成果的交流和传播,建立研究能力 并与其他Moonshot获奖者合作,并支持国家实施科学和癌症 研究社区(网络单元);(4)支持、监督和评估中心进展(评估单元), 这将确保完成拟议的研究,确定该中心的更广泛的影响,并有助于 把建议的研究成果转化为其后获资助的研究项目。首要优先事项 管理核心的目标是确保Penn ISC 3的影响是强大的,并且大于 它的部分。它将通过协调服务和最大限度地发挥研究计划, 实施实验室和其他中心活动。行政核心将与研究中心对接, 定期制定计划(项目PI和方法单元),以确保每个实体都达到目标和目的,以及 必要时解决问题。拟议中的Penn ISC 3将汇集来自以下地区的初级和高级研究人员 多学科,这将创造一个肥沃的环境,长期目标是改善癌症护理 与主要利益攸关方合作,提供服务并对公共卫生产生持续影响。最终 Penn ISC 3行政核心将创造一种卓越的科学文化,并确保中心的成功, 激励和指导新的概念和方法的进步,支持IS的发展, 在宾夕法尼亚州和全国范围内的癌症研究,并在肿瘤学护理中推进实施科学。 PHS 398/2590(Rev.06/09)
英文摘要
This P50 application represents a novel interdisciplinary center at the intersection of behavioral economics and implementation science in pursuit of improving cancer care delivery. The Administrative Core for the University of Pennsylvania Implementation Science Center in Cancer Control (Penn ISC3) will provide overarching operational and scientific oversight. It will be led by the three Penn ISC3 Principal Investigators, Drs. Beidas, Bekelman, and Schnoll, in collaboration with an Internal Executive Committee and an External Advisory Board. The Specific Aims of the Administrative Core are as follows: 1) To provide essential management and integration of Penn ISC3 activities (operational structure),which will include administrative support, meeting coordination, and ensuring the effective use of the Internal Executive Committee and an External Advisory Board; (2) To serve as the hub for implementation science (IS) research in cancer at Penn (IS outreach), which will involve coordination of educational activities, drawing upon essential partnerships at Penn, engage in activities to ensure communication, engaging with other centers funded through this mechanism, and coordinating an annual retreat; (3) To coordinate communication and dissemination of the Center’s research findings, build research capacity and collaboration with other Moonshot awardees, and support a national implementation science and cancer research community (network unit); and (4) To support, monitor, and evaluate Center progress (evaluation unit), which will ensure completion of proposed studies, determine the broader impact of the Center, and help to translate the results of the proposed studies into subsequent funded research projects. The overarching priority for the Administrative Core is to ensure that the impact of the Penn ISC3 is robust and greater than the sum of its parts. It will do so by coordinating services and maximizing synergies among the Research Program, Implementation Laboratory, and other center activities. The Administrative Core will interface with the Research Program (Project PIs and Methods Unit) regularly to ensure that each entity is meeting goals and objectives, and problem solve as necessary. The proposed Penn ISC3 will bring together junior and senior investigators from multiple disciplines, which will create a fertile environment with the long-term goal of improving cancer care delivery and exerting a sustained impact on public health in partnership with key stakeholders. Ultimately, the Penn ISC3 Administrative Core will create a culture of exceptional science and ensure the Center’s success by stimulating and guiding new conceptual and methodological advancements, supporting the growth of IS and cancer research at Penn and nationally, and advancing the science of implementation within oncology care. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
  • 批准号:
    10367999
  • 项目类别:
  • 资助金额:
    $39.22万
  • 财政年份:
    2022
  • 负责人:
    Rinad Sary Beidas
  • 依托单位:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
  • 批准号:
    10689754
  • 项目类别:
  • 资助金额:
    $114.08万
  • 财政年份:
    2021
  • 负责人:
    Rinad Sary Beidas
  • 依托单位:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
  • 批准号:
    10315079
  • 项目类别:
  • 资助金额:
    $72.32万
  • 财政年份:
    2021
  • 负责人:
    Rinad Sary Beidas
  • 依托单位:
海外基金